×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Global Health Limited | 9052.95 | 1519.64 | 8821.56 | 5.65 | 37,386 | 65.6 |
| Narayana Hrudayalaya Limited | 9595.77 | 873.71 | 9431.41 | 4.3 | 36472 | 46.1 |
| IPCA LABORATORIES LTD. | 17719.2 | 2620.4 | 17469.0 | 10.33 | 33499 | 37.4 |
Global Health Limited, with Security Code 543654, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 502.9 | 544.6 | 580.1 | 561.7 | 578.6 | 611.4 | 664.6 | 624.4 | 802.9 | 882.2 |
| Expenses | 400.1 | 435.2 | 451.8 | 439.2 | 456.4 | 479.1 | 514.3 | 484.9 | 607.6 | 687.6 |
| Operating Profit | 102.8 | 109.3 | 128.3 | 122.5 | 122.2 | 132.3 | 150.3 | 139.5 | 195.2 | 194.6 |
| OPM % | 20.45% | 20.08% | 22.12% | 21.81% | 21.12% | 21.64% | 22.62% | 22.35% | 24.32% | 22.06% |
| Other Income | 28.1 | 33.2 | 26.2 | 25.8 | 32.5 | 26.7 | 23.6 | 22.2 | -24.2 | 42.7 |
| Interest | 6.4 | 6.4 | 6.1 | 5.8 | 6.2 | 6.0 | 5.4 | 5.9 | 7.1 | 5.7 |
| Depreciation | 20.4 | 20.4 | 21.5 | 21.7 | 23.4 | 23.3 | 24.9 | 23.4 | 38.0 | 33.4 |
| Profit before tax | 104.2 | 115.7 | 126.9 | 120.9 | 125.2 | 129.7 | 143.6 | 132.3 | 175.8 | 178.7 |
| Tax % | -22.3% | -25.5% | -25.1% | -27.7% | -26.3% | -25.8% | -27.3% | -24.9% | -25.7% | 23.3% |
| Net Profit | 81.0 | 86.2 | 95.1 | 87.3 | 92.2 | 96.3 | 104.5 | 99.3 | 93.4 | 152.0 |
| EPS in Rs | 3.02 | 3.21 | 3.54 | 3.25 | 3.43 | 3.58 | 3.89 | 3.7 | 0 | 5.65 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 694.3 | 703.4 | 773.0 | 843.9 | 832.6 | 808.6 | 861.1 | 956.6 | 943.4 | 931.2 |
| Expenses | 534.3 | 540.3 | 595.2 | 631.1 | 620.5 | 629.3 | 674.8 | 728.3 | 705.7 | 706.5 |
| Operating Profit | 160.0 | 163.1 | 177.9 | 212.9 | 212.1 | 179.3 | 186.3 | 228.3 | 237.8 | 224.7 |
| OPM % | 23.04% | 23.19% | 23.01% | 25.22% | 25.47% | 22.18% | 21.64% | 23.87% | 25.2% | 24.13% |
| Other Income | 11.9 | 28.4 | 21.5 | 20.8 | 21.9 | 27.4 | 21.9 | 18.2 | 16.0 | -27.0 |
| Interest | 20.7 | 20.5 | 17.9 | 20.1 | 17.7 | 18.2 | 18.0 | 16.0 | 16.3 | 15.0 |
| Depreciation | 38.8 | 38.0 | 40.4 | 42.9 | 44.0 | 45.5 | 46.6 | 49.4 | 48.4 | 49.3 |
| Profit before tax | 112.4 | 133.1 | 141.0 | 170.6 | 172.4 | 143.1 | 143.7 | 181.1 | 189.1 | 183.4 |
| Tax % | -28.3% | -24.1% | -27.7% | -26.6% | -28.3% | -11% | 26% | 27.8% | 24.4% | -24% |
| Net Profit | 80.6 | 101.1 | 102.0 | 125.2 | 123.5 | 127.3 | 106.3 | 130.8 | 142.9 | 101.4 |
| EPS in Rs | 3.08 | 3.76 | 3.8 | 4.66 | 4.6 | 4.74 | 3.96 | 4.87 | 5.32 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 17% |
| 3 Years: | 22% |
| TTM: | 41% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 37% |
| 3 Years: | 32% |
| TTM: | 38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | -1% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 20% |
| 3 Years: | 19% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 70% |
| 3 Years: | 38% |
| TTM: | 8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | -1% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|